Effect of constitutive Egr-1 expression on M1myc leukemogenicity
. | Mice dead, % . | . | . | Myeloid leukemic cells recovered from BM† . | ||
---|---|---|---|---|---|---|
Cells* . | 4 wk . | 8 wk . | 12 wk . | . | ||
M1 | ||||||
No IL-6 | 63 | 100 | — | + | ||
With IL-6 | 0 | 0 | 0 | - | ||
M1Egr-1 | ||||||
No IL-6 | 0 | 23 | 100 | + | ||
With IL-6 | 0 | 0 | 0 | - | ||
M1myc | ||||||
No IL-6 | 100 | — | — | + | ||
With IL-6 | 87 | 100 | — | + | ||
M1Egr-1/myc | ||||||
No IL-6 | 53 | 100 | — | + | ||
With IL-6 | 0 | 0 | 0 | - |
. | Mice dead, % . | . | . | Myeloid leukemic cells recovered from BM† . | ||
---|---|---|---|---|---|---|
Cells* . | 4 wk . | 8 wk . | 12 wk . | . | ||
M1 | ||||||
No IL-6 | 63 | 100 | — | + | ||
With IL-6 | 0 | 0 | 0 | - | ||
M1Egr-1 | ||||||
No IL-6 | 0 | 23 | 100 | + | ||
With IL-6 | 0 | 0 | 0 | - | ||
M1myc | ||||||
No IL-6 | 100 | — | — | + | ||
With IL-6 | 87 | 100 | — | + | ||
M1Egr-1/myc | ||||||
No IL-6 | 53 | 100 | — | + | ||
With IL-6 | 0 | 0 | 0 | - |
Each cell type was intravenously injected into 13 nude mice. Cells were treated for 5 days with or without IL-6 (100 ng/mL) prior to inoculation into mice.
Three weeks following inoculation, one mouse injected with each cell type was humanely killed and the BM analyzed for the presence of myeloid leukemic cells.